George Doherty
Inventor
Stats
- 14 US patents issued
- 44 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 14 US Patents Issued
- 44 US Applications Filed
- 145 Total Citation Count
- Aug 15, 2023 Most Recent Filing
- Aug 14, 2000 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| ARRAY BIOPHARMA, INC. | 2
1 | 2007
2012 |
| MERCK & CO., INC. | 1
3 1 | 2000
2002 2003 |
| ABBVIE INC. | 2
4 7 2 8 1 | 2011
2012 2013 2014 2015 2016 |
Inventor Addresses
| Address | Duration |
|---|---|
| Libertyville, IL, US | Jul 08, 10 - Aug 29, 24 |
| Princeton, NJ | Jul 16, 02 - Feb 15, 05 |
| Princeton, NJ, US | Jan 09, 03 - Jan 09, 03 |
| Superior, CO | Sep 13, 05 - Sep 13, 05 |
| Superior, CO, US | May 27, 04 - May 27, 04 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 40 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 13 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0285,611 | 2024 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | 0 |
| 2024/0228,509 | 2024 | MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE | 0 |
| 2024/0199,745 | 2024 | ANTI-EGFR ANTIBODY DRUG CONJUGATES | 0 |
| 2024/0058,450 | 2024 | BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same | 0 |
| 2023/0399,340 | 2023 | MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.